Clinical trial
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial
NCT02875262 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 2, 2022
- Completion date
- June 1, 2024
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.